Bank of America
NNNN

Bank of America’s Anbio Biotechnology NNNN Stock Holding History

Bank of America’s Portfolio NNNN Stock Details NNNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Buy
+13,419
New +$336K ﹤0.01% 5407
2025
Q4 		– Sell
-21
Closed -$782 – 8537
2025
Q3 		$782 Buy
+21
New +$943 ﹤0.01% 7525

Other funds holding NNNN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFS
Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return

Bank of America's NNNN Position: Q2 2026 in Review

Bank of America opened a new position in Anbio Biotechnology (NNNN) in Q2 2026: 13,419 shares worth $184K. The stake represents ﹤0.01% of the portfolio and ranks #5407 among its holdings. This is a return to the name: Bank of America previously reported a position in NNNN as recently as Q3 2025.

Bank of America first reported a position in NNNN in Q3 2025 and has held it in 2 quarters since. 12 funds tracked by Wall St. Rank hold NNNN as of Q2 2026.

  • Bank of America held 13,419 shares of Anbio Biotechnology worth $184K as of Q2 2026.
  • Anbio Biotechnology was a new Bank of America position in Q2 2026.
  • Anbio Biotechnology made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5407 holding.
  • Bank of America first reported a position in Anbio Biotechnology in Q3 2025 and has held it in 2 quarters since.
  • 12 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.